2-48755616-GGCTGCA-GGCTGCAGCTGCA

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1

The NM_000233.4(LHCGR):​c.50_55dupTGCAGC​(p.Leu17_Gln18dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.243 in 1,531,600 control chromosomes in the GnomAD database, including 47,276 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 3903 hom., cov: 25)
Exomes 𝑓: 0.25 ( 43373 hom. )

Consequence

LHCGR
NM_000233.4 conservative_inframe_insertion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts P:1B:7

Conservation

PhyloP100: 0.0830

Publications

2 publications found
Variant links:
Genes affected
LHCGR (HGNC:6585): (luteinizing hormone/choriogonadotropin receptor) This gene encodes the receptor for both luteinizing hormone and choriogonadotropin. This receptor belongs to the G-protein coupled receptor 1 family, and its activity is mediated by G proteins which activate adenylate cyclase. Mutations in this gene result in disorders of male secondary sexual character development, including familial male precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia. [provided by RefSeq, Jul 2008]
STON1-GTF2A1L (HGNC:30651): (STON1-GTF2A1L readthrough) STON1-GTF2A1L mRNAs are infrequent but naturally occurring read-through products of the neighboring STON1 and GTF2A1L genes. These transcripts encode fusion proteins composed of the vast majority of each of the individual elements, stonin 1 and general transcription factor IIA, 1-like. Alternative splicing results in multiple transcript variants. The significance of these read-through variants and the function of the resulting protein products have not yet been determined. [provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_000233.4
BP6
Variant 2-48755616-G-GGCTGCA is Benign according to our data. Variant chr2-48755616-G-GGCTGCA is described in ClinVar as Benign. ClinVar VariationId is 336471.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.264 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LHCGRNM_000233.4 linkc.50_55dupTGCAGC p.Leu17_Gln18dup conservative_inframe_insertion Exon 1 of 11 ENST00000294954.12 NP_000224.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LHCGRENST00000294954.12 linkc.50_55dupTGCAGC p.Leu17_Gln18dup conservative_inframe_insertion Exon 1 of 11 1 NM_000233.4 ENSP00000294954.6
ENSG00000279956ENST00000602369.3 linkn.50_55dupTGCAGC non_coding_transcript_exon_variant Exon 1 of 13 5 ENSP00000473498.1

Frequencies

GnomAD3 genomes
AF:
0.219
AC:
33267
AN:
151786
Hom.:
3909
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.187
Gnomad AMI
AF:
0.358
Gnomad AMR
AF:
0.185
Gnomad ASJ
AF:
0.301
Gnomad EAS
AF:
0.0114
Gnomad SAS
AF:
0.119
Gnomad FIN
AF:
0.188
Gnomad MID
AF:
0.293
Gnomad NFE
AF:
0.267
Gnomad OTH
AF:
0.241
GnomAD2 exomes
AF:
0.190
AC:
25112
AN:
132330
AF XY:
0.189
show subpopulations
Gnomad AFR exome
AF:
0.176
Gnomad AMR exome
AF:
0.126
Gnomad ASJ exome
AF:
0.284
Gnomad EAS exome
AF:
0.0114
Gnomad FIN exome
AF:
0.181
Gnomad NFE exome
AF:
0.270
Gnomad OTH exome
AF:
0.229
GnomAD4 exome
AF:
0.246
AC:
339426
AN:
1379704
Hom.:
43373
Cov.:
34
AF XY:
0.242
AC XY:
164931
AN XY:
680642
show subpopulations
African (AFR)
AF:
0.179
AC:
5608
AN:
31380
American (AMR)
AF:
0.135
AC:
4794
AN:
35526
Ashkenazi Jewish (ASJ)
AF:
0.292
AC:
7308
AN:
24990
East Asian (EAS)
AF:
0.00841
AC:
300
AN:
35686
South Asian (SAS)
AF:
0.131
AC:
10313
AN:
78936
European-Finnish (FIN)
AF:
0.191
AC:
7102
AN:
37190
Middle Eastern (MID)
AF:
0.286
AC:
1157
AN:
4050
European-Non Finnish (NFE)
AF:
0.269
AC:
289229
AN:
1074474
Other (OTH)
AF:
0.237
AC:
13615
AN:
57472
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
12769
25537
38306
51074
63843
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9686
19372
29058
38744
48430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.219
AC:
33261
AN:
151896
Hom.:
3903
Cov.:
25
AF XY:
0.210
AC XY:
15607
AN XY:
74268
show subpopulations
African (AFR)
AF:
0.187
AC:
7743
AN:
41450
American (AMR)
AF:
0.185
AC:
2831
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.301
AC:
1041
AN:
3464
East Asian (EAS)
AF:
0.0114
AC:
59
AN:
5164
South Asian (SAS)
AF:
0.119
AC:
573
AN:
4828
European-Finnish (FIN)
AF:
0.188
AC:
1993
AN:
10596
Middle Eastern (MID)
AF:
0.288
AC:
84
AN:
292
European-Non Finnish (NFE)
AF:
0.267
AC:
18112
AN:
67808
Other (OTH)
AF:
0.238
AC:
502
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
1289
2578
3867
5156
6445
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.173
Hom.:
446
Asia WGS
AF:
0.0840
AC:
295
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Aug 23, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 26, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 24, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Luteinizing hormone/choriogonadotropin receptor, lq variant Pathogenic:1
Apr 01, 2003
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Hypergonadotropic hypogonadism Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leydig cell agenesis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gonadotropin-independent familial sexual precocity Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.083
Mutation Taster
=87/13
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71245621; hg19: chr2-48982755; COSMIC: COSV54295979; COSMIC: COSV54295979; API